Delcor Asset Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DELCOR ASSET CORP, and what generic and branded alternatives to DELCOR ASSET CORP drugs are available?
DELCOR ASSET CORP has seventeen approved drugs.
Summary for Delcor Asset Corp
| US Patents: | 0 |
| Tradenames: | 7 |
| Ingredients: | 6 |
| NDAs: | 17 |
Drugs and US Patents for Delcor Asset Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delcor Asset Corp | MYCOSTATIN | nystatin | SUSPENSION;ORAL | 061533-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Delcor Asset Corp | KENACORT | triamcinolone | TABLET;ORAL | 011283-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Delcor Asset Corp | PHENERGAN | promethazine hydrochloride | TABLET;ORAL | 007935-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Delcor Asset Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Delcor Asset Corp | KENALOG-H | triamcinolone acetonide | CREAM;TOPICAL | 086240-001 | Approved Prior to Jan 1, 1982 | 4,048,310 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
